The pharmacologic basis for the treatment of developmental and acute laminitis.
The treatment of laminitis has been fraught with confusion and controversy for several decades, mainly because of a lack of understanding of the pathophysiology of the disease process. However, recent advances in laminitis research have greatly improved our understanding of the disease process. This article discusses the various treatment options for laminitis in the context of the findings of recent scientific investigations of laminitis pathophysiology.
Belknap
James K
JK
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Ohio State University, Columbus, OH 43210, USA. james.belknap@cvm.osu.edu
D000208:Acute Disease; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use; D005534:Foot Diseases / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary*; D006724:Hoof and Claw / Q000098:blood supply* / Q000473:pathology; D006734:Horse Diseases / Q000188:drug therapy* / Q000503:physiopathology; D006736:Horses; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D014665:Vasodilator Agents